Kayexalate

Kayexalate is a brand name of sodium polystyrene sulfonate, approved by the FDA in the following formulation(s):

KAYEXALATE (sodium polystyrene sulfonate - powder; oral, rectal)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 453.6GM/BOT ^[RLD][AA]

Has a generic version of Kayexalate been approved?

Yes. The following products are equivalent to Kayexalate:

sodium polystyrene sulfonate powder; oral, rectal

• 
  Manufacturer: CEDAR PHARMS
  
  Approval date: December 21, 2011
  
  Strength(s): 453.6GM/BOT ^[AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Kayexalate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Kayexalate.

See also...

• Kayexalate Powder Consumer Information (Wolters Kluwer)
• Kayexalate Consumer Information (Cerner Multum)
• Kayexalate Advanced Consumer Information (Micromedex)
• SPS Suspension Consumer Information (Wolters Kluwer)
• Sodium Polystyrene Sulfonate Powder Consumer Information (Wolters Kluwer)
• Sodium Polystyrene Sulfonate Suspension Consumer Information (Wolters Kluwer)
• Sodium polystyrene sulfonate Consumer Information (Cerner Multum)
• Pms-Sodium Polystyrene Sulfonate Advanced Consumer Information (Micromedex)
• Sodium polystyrene sulfonate Advanced Consumer Information (Micromedex)
• Sodium polystyrene sulfonate Rectal Advanced Consumer Information (Micromedex)
• Sodium Polystyrene Sulfonate AHFS DI Monographs (ASHP)